Travere Therapeutics (TVTX)
(Delayed Data from NSDQ)
$9.00 USD
-0.24 (-2.60%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $9.00 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, Travere Therapeutics (TVTX) reported earnings of -$0.90 per share, missing the Zacks Consensus Estimate of -$0.87 per share. This reflects a negative earnings surprise of 3.45%. Look out for TVTX's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year increase of 40.17%.
Earnings History
Price & Consensus
Zacks News for TVTX
Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates
TVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services